A Study On KC Pharmaceutical Company Of Cost Leadership Strategy

In recent years, the pharmaceutical industry increasingly fierce competition, thesurvival of the business environment becomes more difficult, the pharmaceuticalenterprises are facing many threats of adverse factors. For example, large internationalpharmaceutical enterprises to enter the domestic market, prices fell, the threat ofproduction material prices, domestic labor costs, transportation costs are rising, somany pharmaceutical enterprise profit space is compressed constantly. In this paper,we use the theories of strategic management, through the introduction of rawmaterials and raw material medicine industry characteristics, using the five forcesmodel to analyze the competitiveness of the industry,"SWOT" model analysis of KCpharmaceutical advantage, weakness, opportunity and threat, points out the necessityof implement the cost leading strategy of KC pharmaceutical, discussing theimplementation of cost leadership strategy measure and evaluate effect of. By lookingfor common problems need to pay attention to the implementation of cost leadershipstrategy similar enterprises, solve the method further explore these questions andrelated improvement measures, improve the KC pharmaceutical cost leading strategycontent and response mechanism, and draw some general conclusions in response tothe increasingly complex competition environment of the strategic choice of theenterprise to produce similar KC pharmaceutical raw materials medicine, provide theexperience for the similar enterprise to cost leading strategy. Of course, for the KCindustry, the production characteristics of raw materials, the accumulation oftechnology and experience, enhance the ability of drug development, finally able toown a space for one person in a finished drug patent medicine, etc..